• Je něco špatně v tomto záznamu ?

Antifungal activity of silver nanoparticles against Candida spp

A. Panáček, M. Kolář, R. Večeřová, R. Prucek, J. Soukupová, V. Kryštof, P. Hamal, R. Zbořil, L. Kvítek

. 2009 ; 30 (31) : 6333-6340.

Jazyk angličtina Země Velká Británie

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc11022366

The antifungal activity of the silver nanoparticles (NPs) prepared by the modified Tollens process was evaluated for pathogenic Candida spp. by means of the determination of the minimum inhibitory concentration (MIC), minimum fungicidal concentration (MFC), and the time-dependency of yeasts growth inhibition. Simultaneously the cytotoxicity of the silver NPs to human fibroblasts was determined. The silver NPs exhibited inhibitory effect against the tested yeasts at the concentration as low as 0.21 mg/L of Ag. The inhibitory effect of silver NPs was enhanced through their stabilization and the lowest MIC equal to 0.05 mg/L was determined for silver NPs stabilized by sodium dodecyl sulfate against Candida albicans II. The obtained MICs of the silver NPs and especially of the stabilized silver NPs were comparable and in some cases even better than MICs of the conventional antifungal agents determined by E-test. The silver NPs effectively inhibited the growth of the tested yeasts at the concentrations below their cytotoxic limit against the tested human fibroblasts determined at a concentration equal to 30 mg/L of Ag. In contrast, ionic silver inhibited the growth of the tested yeasts at the concentrations comparable to the cytotoxic level (approx. 1mg/L) of ionic silver against the tested human fibroblasts.

Citace poskytuje Crossref.org

000      
02738naa 2200397 a 4500
001      
bmc11022366
003      
CZ-PrNML
005      
20221005143525.0
008      
110729s2009 xxk e Eng||
009      
AR
024    7_
$a 10.1016/j.biomaterials.2009.07.065 $2 doi
035    __
$a (PubMed)19698988
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Panáček, Aleš, $d 1978- $7 jx20070503016
245    10
$a Antifungal activity of silver nanoparticles against Candida spp / $c A. Panáček, M. Kolář, R. Večeřová, R. Prucek, J. Soukupová, V. Kryštof, P. Hamal, R. Zbořil, L. Kvítek
314    __
$a Department of Physical Chemistry, Faculty of Science, Palacky University, Olomouc 771 46, Czech Republic.
520    9_
$a The antifungal activity of the silver nanoparticles (NPs) prepared by the modified Tollens process was evaluated for pathogenic Candida spp. by means of the determination of the minimum inhibitory concentration (MIC), minimum fungicidal concentration (MFC), and the time-dependency of yeasts growth inhibition. Simultaneously the cytotoxicity of the silver NPs to human fibroblasts was determined. The silver NPs exhibited inhibitory effect against the tested yeasts at the concentration as low as 0.21 mg/L of Ag. The inhibitory effect of silver NPs was enhanced through their stabilization and the lowest MIC equal to 0.05 mg/L was determined for silver NPs stabilized by sodium dodecyl sulfate against Candida albicans II. The obtained MICs of the silver NPs and especially of the stabilized silver NPs were comparable and in some cases even better than MICs of the conventional antifungal agents determined by E-test. The silver NPs effectively inhibited the growth of the tested yeasts at the concentrations below their cytotoxic limit against the tested human fibroblasts determined at a concentration equal to 30 mg/L of Ag. In contrast, ionic silver inhibited the growth of the tested yeasts at the concentrations comparable to the cytotoxic level (approx. 1mg/L) of ionic silver against the tested human fibroblasts.
590    __
$a bohemika - dle Pubmed
650    _2
$a antifungální látky $x farmakologie $7 D000935
650    _2
$a Candida $x účinky léků $7 D002175
650    _2
$a buněčné linie $7 D002460
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a lidé $7 D006801
650    _2
$a kovové nanočástice $x terapeutické užití $7 D053768
650    _2
$a stříbro $x farmakologie $7 D012834
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kolář, Milan, $d 1964- $7 jn20010310083
700    1_
$a Večeřová, Renata $7 xx0114985
700    1#
$a Prucek, Robert. $7 _AN053488
700    1#
$a Soukupová, Jana. $7 _AN056459
700    1_
$a Kryštof, Vladimír, $d 1973- $7 xx0097406
700    1_
$a Hamal, Petr $7 xx0060595
700    1_
$a Zbořil, Radek, $d 1973- $7 xx0140669
700    1_
$a Kvítek, Libor, $d 1960- $7 kup19960000054713
773    0_
$t Biomaterials $w MED00000753 $g Roč. 30, č. 31 (2009), s. 6333-6340
910    __
$a ABA008 $b x $y 2 $z 0
990    __
$a 20110801151025 $b ABA008
991    __
$a 20221005143520 $b ABA008
999    __
$a ok $b bmc $g 881751 $s 732286
BAS    __
$a 3
BMC    __
$a 2009 $x MED00000753 $b 30 $c 31 $d 6333-6340 $m Biomaterials $n Biomaterials
LZP    __
$a 2011-4B09/jvme

Najít záznam

Citační ukazatele

Nahrávání dat ...